CapsoVision, Inc
CV · XNASCIK 1378325fmd_1YFW20X0SVRY0B3MBSTN4KDXYWManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2024 to Sep 30, 2026, 11 periods
| Line item | FY2024 | FY2025 |
|---|---|---|
| Total revenues | 12 | 14 |
| Cost of revenue | 5 | 6 |
| Gross profit | 6 | 7 |
| Research and development | 15 | 18 |
| Selling, general and administrative | 11 | 14 |
| Total operating expenses | 26 | 33 |
| Operating income | (20) | (26) |
| Other non-operating income (expense) | 0 | 0 |
| Income before taxes | (20) | (25) |
| Income tax expense | 0 | 0 |
| Net income from continuing operations | (20) | (25) |
| Net income | (20) | (25) |
| Net income to common shareholders | (20) | (25) |